Contractile Effects of Semaglutide in the Human Atrium

Contractile Effects of Semaglutide in the Human Atrium

Semaglutide is a glucagon-like peptide 1 receptor (GLP-1R) agonist. GLP-1R agonists are used to treat type 2 diabetes and obesity. It is currently unknown whether semaglutide can directly increase force of contraction (FOC) in the human heart. We tested the hypothesis that semaglutide might increase...

Full description

Bibliographic Details
Main Authors: Joachim Neumann, Katarína Hadová, Jan Klimas, Britt Hofmann, Ulrich Gergs
Format: Article
Language:English
Published: MDPI AG 2024-08-01
Series:Pharmaceutics
Subjects:
semaglutide
GLP-1 receptor
human atrium
inotropy
Online Access:https://www.mdpi.com/1999-4923/16/9/1139

Internet

https://www.mdpi.com/1999-4923/16/9/1139

Similar Items